Haleon: A Defensive Consumer Health Leader
UK multi-national company Haleon is a global leader in the growing consumer health...
Still tarrified, or just a bump in the night?
The volatility seen in markets over the past month suggests...
It’s results season in the US, with all eyes on some of the world’s largest companies. Milford Portfolio Manager and...
We are delighted to have been named Consumer NZ People’s Choice KiwiSaver Provider for the eighth consecutive year.
The...
Reporting out of the US this week reveals that Trump’s tariffs are real and beginning to bite. Milford Portfolio Manager...
What sectors have performed well on the share market, despite the recent sell off? Milford Senior Investment Analyst Stephanie
...
Diversification is a popular concept when it comes to investing, but what does it actually involve? Milford Financial Adviser Bruce...
The Reserve Bank (RBNZ) has cut the Official Cash Rate by 25 basis points to 3.5 per cent – a...
Senior Investment Analyst Stephanie Batchelor talks through the current market volatility and what it means for Investors.
...
A lot has changed in the two weeks since Milford’s Head of Wealth Management, Philip Morgan Rees, spoke with Ryan...
Tarrified
In a volatile month Milford funds fared well, and although some of our fund returns were negative, we...
Ryman Healthcare – is the worst now behind it?:
Ryman Healthcare has been in the news again after just...
Tomorrow’s tariff announcement by President Trump is widely anticipated around the globe. Milford Investment Analyst Jeremy Hutton talks to Ryan...
Ryman Healthcare has been in the news recently, raising $1bn of new equity – it’s second raise in two years....
A $20m half-year loss reported by KMD Brands, parent company of Kathmandu and Rip Curl, follows a torrid time for...
Investing may be a long-game, but how do you stand firm when the ground is shaky? Milford Head of Wealth...
US markets are down 8% from their high in February, driven by a growing view the country might be seeing...
